Addiction: all studies (page 29) - The Consciousness Library

Mindfulness-oriented recovery enhancement in opioid use disorder: Extended emotional regulation and neural effects and immediate effects of guided meditation in a pilot sample.

Explore 2024 Suchismita Ray, Jamil Bhanji, Nicole R Kennelly et al.

Mindfulness-Oriented Recovery Enhancement (MORE) is an efficacious intervention to aid recovery from substance use disorder. This study in a pilot sample of individuals in treatment for opioid use disorder (OUD) characterizes longer-term changes after the MORE intervention and immediate effects of a brief MORE guided meditation session. Twelve female participants in residential treatment for...

DOI: 10.1016/j.explore.2023.11.001 Full text Mindfulness Opioid use disorder Connectivity Emotion +2

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.

Frontiers in Psychiatry 2024 David J Heal, Jane Gosden, Sharon L. Smith

Various countries and US States have legalized cannabis, and the use of the psychoactive1 and non-psychoactive cannabinoids is steadily increasing. In this review, we have collated evidence from published non-clinical and clinical sources to evaluate the abuse, dependence and associated safety risks of the individual cannabinoids present in cannabis. As context, we also evaluated various...

DOI: 10.3389/fpsyt.2024.1322434 Full text Cannabis Dependence THC - Tetrahydrocannabinol Abuse +2

A scoping review of spirituality in relation to substance use disorders: Psychological, biological, and cultural issues.

Journal of Addictive Diseases 2024 Marc Galanter, William L White, Jag Khalsa et al. 14 citations

Spirituality is a construct encompassing a diversity of strongly held beliefs and pursuits related to life's meaning and purpose. Empirical studies in key domains of spirituality related to substance use disorder (SUD) can be valuable in guiding research, and potentially clinical care. To conduct a scoping review of research on the psychological, biological, and cultural dimensions of...

DOI: 10.1080/10550887.2023.2174785 Full text Addiction Alcoholics anonymous Narcotics anonymous Spirituality +1

Government-funded trial will test psilocybin as treatment for opioid use disorder

Pharmaceutical journal/The pharmaceutical journal 2024

A “UK first” trial will investigate whether psilocybin — the active ingredient in ‘magic mushrooms’ — can help prevent relapse in people recovering from opioid addiction. The psilocybin study, led by researchers at Imperial College London, will involve 28 participants who have recently undergone detoxification from ‘street’ opioids. Participants will receive psilocybin therapy at the […]

DOI: 10.1211/pj.2024.1.335169

Mindfulness-based relapse prevention targeting psychological craving and trait mindfulness in young Chinese women with methamphetamine dependence: a randomized controlled trial.

Frontiers in Psychiatry 2024 Xuan Liu, Yidan Zhang, Hongxin Cheng et al. 3 citations

We recruited 58 MA-dependent young adult females from a compulsory isolation drug rehabilitation center in Sichuan Province and randomly divided them into an MBRP group (n = 29) and a control group (n = 29) according to their degree of psychological craving. The MBRP group received 2 hours of MBRP training twice a week for 4 weeks, alongside routine treatment at the drug rehabilitation center....

DOI: 10.3389/fpsyt.2024.1339517 Full text Ma-dependent Mbrp Female Psychological craving +1

A mindfulness-based intervention for Substance Use Disorder in a Brazilian vulnerable population: a feasibility mixed method study.

Frontiers in Public Health 2024 Mayra Pires Alves Machado, Emérita Sátiro Opaleye, Andre Bedendo et al. 3 citations

Substance Use Disorder (SUD) is a chronic condition that impacts various facets of an individual's life, and society as a whole. The Mindfulness-Based Relapse Prevention (MBRP) protocol is an innovative intervention that can help to prevent relapse, particularly when used as a post-treatment approach. However, although there is significant evidence of its effectiveness in studies from...

DOI: 10.3389/fpubh.2024.1381489 Full text Meditation Mindfulness Substance use disorder Feasibility +4

Three Decades of Research on the Development of Ibogaine Treatment of Substance Use Disorders: A Scientometric Analysis.

Journal of Psychoactive Drugs 2024 Maria Helha Fernandes-Nascimento, André Brooking Negrão, Karine Viana-Ferreira et al. 7 citations

Ibogaine is a natural psychoactive drug that has been investigated for its potential role in the treatment of substance use disorders since the mid-1960s. To evaluate the interest in ibogaine's use as a therapeutic agent, we performed a scientometric analysis covering the last three decades (1993-2002, 2003-2012, and 2013-2022). A complementary analysis was performed to select and describe...

DOI: 10.1080/02791072.2023.2276230 Full text Opioid use disorder Psychedelic therapy Psychedelic-assisted therapy Citespace, psychedelics +24

IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.

Pharmacological Research 2024 David B. Yaden, Andrea P Berghella, Peter S. Hendricks et al. 12 citations

Substance use disorders (SUDs) have an enormous impact on public health. With classic psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is possible that these treatments will become legally available options for patients with SUDs in the future. This article highlights how classic psychedelic-assisted therapies might be integrated into current clinical...

DOI: 10.1016/j.phrs.2023.106998 Full text Psilocybin Substance use disorder Psychedelic therapy Medication assisted treatment +5

Ayahuasca for the treatment of alcohol use disorder.

International review of neurobiology 2024 Eduardo A V Marinho, Yasmim A. Serra, Alexandre J. Oliveira-Lima et al. 6 citations

For decades, psychedelics have been investigated for the treatment of psychiatric disorders. Specifically, evidence suggests that psychedelics may have therapeutic potential for the treatment of alcohol use disorder. Several studies with classic psychedelics, including LSD and psilocybin, show promising results, with psychedelics decreasing alcohol drinking and promoting abstinence in...

DOI: 10.1016/bs.irn.2024.07.007 Full text Alcohol use disorder Ayahuasca Rehabilitation Entheogens +6

Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy.

Journal of Psychopharmacology December 1, 2023 Brian J Gully, Erica Eaton, Christy Capone et al. 12 citations

Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) frequently co-occur in patients who have experienced trauma. This comorbidity leads to a vicious cycle where PTSD symptoms beget heavy drinking and vice versa. There are no FDA-approved medications to treat PTSD-AUD; therefore, individuals suffering from this comorbidity are treated with medication approved to treat the...

DOI: 10.1177/02698811231200880 Full text Alcohol use disorder Comorbidity Posttraumatic stress disorder Psychedelics